Skip to main navigation Skip to search Skip to main content

Nanomedicine-based cancer immunotherapy: recent trends and future perspectives

  • Vinoth Kumar Lakshmanan
  • , Shlok Jindal
  • , Gopinath Packirisamy
  • , Shreesh Ojha
  • , Sen Lian
  • , Ajeet Kaushik
  • , Abdulqadir Ismail M.Abdullah Alzarooni
  • , Yasser Abdelraouf Farahat Metwally
  • , Sadras Panchatcharam Thyagarajan
  • , Young Do Jung
  • , Salem Chouaib
  • Sri Ramachandra Institute of Higher Education and Research
  • Indian Institute of Technology Roorkee
  • Southern Medical University
  • Florida Polytechnic University
  • Pathology and Laboratory Medicine, Department at Sheikh Khalifa General Hospital
  • Chonnam National University
  • Unité INSERM U753, Institut de Cancérologie Gustave Roussy

Research output: Contribution to journal › Review article › peer-review

72 Scopus citations

Abstract

The combination of cancer immunotherapy with efficient functionalized nanosystems has emerged as a beneficial treatment strategy and its use has increased rapidly. The roles of stimuli-responsive nanosystems and nanomedicine-based cancer immunotherapy, a subsidiary discipline in the field of immunology, are pivotal. The present era is witnessing rapid advancements in the use of nanomedicine as a platform for investigating novel therapeutic applications and modern intelligent healthcare management strategies. The development of cancer nanomedicine has posthaste ratified the outcomes of immunotherapy to the subsequent stage in the current era of medical research. This review focuses on key findings with respect to the effectiveness of nanomedicine-based cancer immunotherapies and their applications, which include i) immune checkpoint inhibitors and nanomedicine, ii) CRISPR-Cas nanoparticles (NPs) in cancer immunotherapy, iii) combination cancer immunotherapy with core-shell nanoparticles, iv) biomimetic NPs for cancer immunotherapy, and v) CAR-T cells and cancer nanoimmunotherapy. By evaluating the state-of-the-art tools and taking the challenges involved into consideration, various aspects of the proposed nano-enabled therapeutic approaches have been discussed in this review.

Original languageEnglish
Pages (from-to)911-923
Number of pages13
JournalCancer Gene Therapy
Volume28
Issue number9
DOIs
StatePublished - Sep 2021

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Nanomedicine-based cancer immunotherapy: recent trends and future perspectives'. Together they form a unique fingerprint.

Cite this